Peptide Info
BPC‑157 Peptide for Research Use: Preclinical Overview
What is BPC‑157?
BPC‑157 is a synthetic peptide derived from a naturally occurring protein in human gastric juice. Composed of 15 amino acids, BPC‑157 has become a focus of preclinical studies due to its potential in tissue regeneration, angiogenesis, and cellular protection. This compound is strictly sold for research use only and is not approved for human or veterinary use.
BPC‑157 (Body Protection Compound 157) is part of a class of experimental peptides that researchers are actively investigating for their regenerative properties. Its molecular weight is approximately 1,419.5 Da, and its sequence is Gly‑Glu‑Pro‑Pro‑Pro‑Gly‑Lys‑Pro‑Ala‑Asp‑Asp‑Ala‑Gly‑Leu‑Val.
PeptideResearchHub offers high-purity BPC‑157 5mg for authorized research professionals only.
Preclinical Applications of BPC‑157
To date, BPC‑157 has shown promise in numerous animal and in vitro models. Key areas of interest include:
- Tendon and ligament regeneration
- Gastrointestinal protection
- Neuroprotection and brain trauma recovery
- Angiogenesis and improved wound healing
- Anti-inflammatory responses in soft tissue
Researchers have observed accelerated healing and improved blood vessel formation in rat and mouse models. These findings have made BPC‑157 an appealing target for further scientific investigation.
Mechanisms of Action
Although BPC‑157’s mechanisms are still under investigation, evidence suggests it may influence the nitric oxide (NO) system, upregulate VEGF (vascular endothelial growth factor), and interact with growth hormone receptors in localized tissue injury sites. These activities contribute to its potential roles in tissue repair and anti-inflammatory signaling pathways.
Safety & Toxicology
To date, no human clinical trials have been completed on BPC‑157. All available safety data come from rodent and canine studies, which report no significant toxicity or organ damage under normal research conditions. No lethal dose (LD50) has been established.
Because BPC‑157 is not FDA-approved and has no established clinical use, it is strictly offered for preclinical laboratory research only. No health claims are made or implied by its availability.
Regulatory Status
BPC‑157 is listed under the World Anti-Doping Agency (WADA) category S0, indicating it is a prohibited substance in professional sports. The FDA has issued warnings against marketing it for human use. As a result, BPC‑157 should be handled only in appropriate lab settings with proper documentation.
Why Researchers Choose BPC‑157
- Potential for tissue regeneration – especially in soft tissues
- Preliminary angiogenesis support – promotes blood flow to injured sites
- Neuroprotective observations – in early animal models of brain injury
- Gastrointestinal protection – including ulcer and intestinal lesion models
- Availability in stable lyophilized form – ideal for long-term study
These factors contribute to why BPC‑157 is one of the most sought-after compounds among peptide researchers today.
Available Format
PeptideResearchHub supplies BPC‑157 5mg in a high-purity, lyophilized format, ideal for experimental reconstitution and use in laboratory settings. All batches are tested for identity, purity, and consistency.
Disclaimer
Disclaimer: This compound is sold strictly for research use only. It is not intended for human consumption, clinical use, or inclusion in personal care products. All information presented is for scientific reference only.
To explore more research peptides and learn about ongoing compound studies, visit our full product catalog.
